REUTERS/Francois Lenoir
A man stands inside the Belgian headquarters of U.S. pharmaceutical giant Pfizer, in Brussels.
According to Bloomberg, the drug behemoth expects to submit palbociclib NDA with the FDA early in Q3 of this year.
Palbociclib is the compound name for a breast ancer drug in Pfizer's pipeline that has been in phase 3 trials.
News of Pfizer's trading halt had a lot of folks atwitter, speculating that there was an announcement coming regarding the company's proposed takeover of AstraZeneca.